REVA Medical Inc. Release: Presentation of Interim Clinical Results at TCT Conference
10/24/2012 8:46:17 AM
SAN DIEGO, Oct. 23, 2012 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased to announce that a clinical update on patients from its RESTORE pilot study is being presented at the Transcatheter Therapeutics Conference, the world's largest interventional cardiology meeting, which is being held this week in Miami, Florida. Reporting on the results is Dr. Ricardo Costa from the Dante Pazzanese Institute de Cardiologie, a leading enrollment center for the trial located in Sao Paulo, Brazil.
comments powered by